Wayne Hummer Investments L.L.C. reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 17.6% during the third quarter, Holdings Channel reports. The institutional investor owned 12,042 shares of the pharmacy operator’s stock after selling 2,572 shares during the period. Wayne Hummer Investments L.L.C.’s holdings in Walgreens Boots Alliance were worth $971,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Hudock Capital Group LLC increased its stake in Walgreens Boots Alliance by 0.4% in the third quarter. Hudock Capital Group LLC now owns 1,641 shares of the pharmacy operator’s stock worth $132,000 after buying an additional 7 shares in the last quarter. Signaturefd LLC increased its stake in Walgreens Boots Alliance by 2.7% in the second quarter. Signaturefd LLC now owns 1,802 shares of the pharmacy operator’s stock worth $150,000 after buying an additional 48 shares in the last quarter. Exane Derivatives increased its stake in Walgreens Boots Alliance by 56.3% in the third quarter. Exane Derivatives now owns 1,884 shares of the pharmacy operator’s stock worth $152,000 after buying an additional 679 shares in the last quarter. Van Hulzen Asset Management LLC purchased a new stake in Walgreens Boots Alliance during the second quarter worth about $159,000. Finally, Country Trust Bank increased its stake in Walgreens Boots Alliance by 14.5% in the third quarter. Country Trust Bank now owns 2,370 shares of the pharmacy operator’s stock worth $191,000 after buying an additional 300 shares in the last quarter. 60.15% of the stock is owned by institutional investors and hedge funds.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.78% on Tuesday, hitting $81.43. The stock had a trading volume of 4,174,804 shares. The company’s 50 day moving average price is $82.83 and its 200 day moving average price is $82.15. Walgreens Boots Alliance, Inc. has a 52-week low of $73.88 and a 52-week high of $88.00. The firm has a market cap of $87.90 billion, a price-to-earnings ratio of 21.55 and a beta of 1.20.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, January 5th. The pharmacy operator reported $1.10 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.09 by $0.01. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. The business earned $28.50 billion during the quarter. During the same quarter in the previous year, the company posted $1.03 EPS. The company’s quarterly revenue was down 1.8% on a year-over-year basis. Analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 10th. Shareholders of record on Wednesday, February 15th will be paid a $0.375 dividend. The ex-dividend date is Monday, February 13th. This represents a $1.50 dividend on an annualized basis and a yield of 1.84%. Walgreens Boots Alliance’s payout ratio is presently 39.68%.
A number of research firms have issued reports on WBA. Evercore ISI reissued a “buy” rating and issued a $93.00 target price on shares of Walgreens Boots Alliance in a research report on Tuesday, January 31st. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price target for the company in a report on Tuesday, January 17th. Jefferies Group LLC set a $95.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Tuesday, November 8th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a report on Friday, October 21st. Finally, Atlantic Securities raised Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 price target for the company in a report on Monday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $91.38.
In other Walgreens Boots Alliance news, Director Janice M. Babiak purchased 600 shares of the business’s stock in a transaction on Thursday, February 2nd. The stock was acquired at an average price of $80.68 per share, for a total transaction of $48,408.00. Following the purchase, the director now owns 600 shares of the company’s stock, valued at approximately $48,408. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Kathleen Wilson-Thompson sold 5,700 shares of the stock in a transaction on Monday, November 28th. The stock was sold at an average price of $85.05, for a total value of $484,785.00. The disclosure for this sale can be found here. Corporate insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).